RPL14P1

Across TCGA pan-cancer cohorts, RPL14P1 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RPL14P1 data layer compared with 3 for mutation status and 3 for mass-spec protein.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RPL14P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL14P1 expression acts as an unfavorable survival marker, although some lineages such as THCA and BRCA show a favorable association.

ACC, KICH, and THCA are the cancer types where RPL14P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.261	0.616	<.001	79	view →
KICH	DFS	Median	All	0.694	1.000	.008	58	view →
THCA	OS	Median	All	1.000	0.979	<.001	56	view →
BRCA	OS	Tertile	III,IV	0.745	0.454	.004	39	view →
LIHC	OS	Median	All	0.712	0.846	.003	36	view →
PAAD	DFS	Quartile	All	0.335	0.604	.004	28	view →
LUAD	OS	Tertile	III,IV	0.296	0.683	.003	26	view →
SARC	DFS	Quartile	All	0.500	0.755	<.001	23	view →
STAD	OS	Quartile	All	0.607	0.742	.017	21	view →
BLCA	DFS	Median	III,IV	0.613	0.363	.003	18	view →
READ	DFS	Tertile	II,III,IV	0.891	0.706	.018	16	view →
UVM	DFS	Median	II,III,IV	0.814	0.410	<.001	16	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RPL14P1–ACC (DFS)

Open the ACC breakdown →